| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
750 |
654 |
$42K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
367 |
329 |
$39K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
337 |
310 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
125 |
117 |
$10K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
299 |
289 |
$10K |
| 87634 |
|
48 |
46 |
$3K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
324 |
323 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
42 |
40 |
$985.74 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
30 |
26 |
$928.50 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
85 |
85 |
$872.95 |
| 0072A |
|
17 |
17 |
$779.96 |
| 0071A |
|
17 |
17 |
$779.96 |
| 96127 |
|
73 |
73 |
$749.71 |
| 94760 |
|
329 |
298 |
$727.87 |
| 90461 |
|
13 |
13 |
$403.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15 |
15 |
$306.75 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
24 |
12 |
$293.52 |
| 99051 |
|
12 |
12 |
$198.72 |